Centene Corporation
NYSE:CNCMedical - Healthcare Plans
+$0.67 today
- Market cap
- $33.39B
- Beta
- 1.09
- P/E (TTM)
- -4.7
- EPS (TTM)
- -$13.09
Volume 6.29M
Average 6.16M
CNC Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Centene CorporationNYSE: CNC
Net Income · Q2 FY2026 · quarter ended Jun 2026
Net income turns positive
Q2 FY2026 net income was $1.09B, compared with -$259M a year earlier. Trailing-twelve-month net income was -$5.11B.
Context
- Net income amounted to 3.4% of revenue in FY2025, up 1.4 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 12 analysts of $2.62B (+139.2%) for the fiscal year ending Dec 2026, a step up from the -302.7% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $1.09B-29.4% QoQ
- Last fiscal yearDec 2025
- -$6.68B-302.7% YoY
- LTMJun 2026
- -$5.11B-350.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +519.7% | +100.7% | -419.0 pp |
| 1 year | -302.7% | +139.2% | +441.9 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (6.68B) USD
- Year-over-year change
- -302.7%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (6.68B) | -302.7% |
| FY2024 | 2024-12-31 | 3.29B | +21.9% |
| FY2023 | 2023-12-31 | 2.7B | +124.8% |
| FY2022 | 2022-12-31 | 1.2B | -10.0% |
| FY2021 | 2021-12-31 | 1.34B | — |
Net Income vs competitors
How CNC compares with its peers on the latest reported figures
- CNC's LTM Jun 2026 net income of $5.11B is the 4th largest of the 9 companies compared; the peer median is $3.17B.
- Its year-over-year change of -350.3% is the lowest of 9, against a peer median of -0.8%.
- Net income amounts to 2.6% of revenue for CNC, versus a peer median of 1.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $16.67B | -8.1% | -14.0% | 3.7% | |
| LTM Sep 2026 | $6.71B | +2.4% | -2.5% | 2.3% | |
| LTM Jun 2026 | $6.1B | +35.6% | -26.4% | 1.5% | |
| LTM Jun 2026 | $5.11B | -350.3% | — | 2.6% | |
| LTM Sep 2026 | $5.1B | -7.7% | -2.0% | 2.5% | |
| LTM Sep 2026 | $1.24B | -3.9% | -24.6% | 0.8% | |
| LTM Jun 2026 | $550.93M | +443.4% | -10.1% | 3.6% | |
| LTM Sep 2026 | $48M | -105.4% | -15.8% | 0.1% | |
| LTM Mar 2026 | $19.79M | +121.8% | -83.1% | 0.5% | |
| Peer median (excluding CNC) | $3.17B | -0.8% | -14.9% | 1.9% | |
Competitors are the stored peer set for CNC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.34B | 1.2B | 2.7B | 3.29B | (6.68B) |
| Depreciation & Amortization | 1.48B | 1.55B | 1.29B | 1.24B | 1.28B |
| Deferred Income Tax | (132M) | (631M) | (78M) | 13M | (60M) |
| Stock-Based Compensation | 203M | 234M | 216M | 212M | 204M |
| Change in Working Capital | 1.38B | 2.19B | 3.37B | (4.52B) | 823M |
| Accounts Receivables | (2.45B) | (1.63B) | (2.38B) | (4.33B) | 1.48B |
| Inventory | (1.14B) | 0 | 2.12B | 0 | 0 |
| Accounts Payables | 1.14B | 421M | 3.4B | (528M) | (657M) |
| Other Working Capital | 3.83B | 3.4B | 234M | 346M | 0 |
| Other Non-Cash Items | (54M) | 1.71B | 546M | (91M) | 9.52B |
| Operating Cash Flow | 4.21B | 6.26B | 8.05B | 154M | 5.09B |
| Capital Expenditures | (910M) | (1B) | (799M) | (644M) | (767M) |
| Acquisitions (Net) | (466M) | 1.02B | 619M | 990M | (19M) |
| Purchases of Investments | (7.4B) | (6.74B) | (6.62B) | (7.18B) | (4.54B) |
| Sales of Investments | 5.46B | 3.8B | 5.52B | 5.79B | 5.78B |
| Other Investing Activities | 19M | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (3.3B) | (2.92B) | (1.28B) | (1.05B) | 453M |
| Debt Repayment | 1.76B | (1.13B) | 19M | 678M | (1.15B) |
| Common Stock Issued | 0 | 70M | 44M | 46M | 37M |
| Common Stock Repurchased | (297M) | (3.1B) | (1.63B) | (3.12B) | (475M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (102M) | (41M) | 0 | (6M) | (19M) |
| Financing Cash Flow | 1.36B | (4.2B) | (1.57B) | (2.41B) | (1.6B) |
| Effect of Forex Changes | 50M | (187M) | (85M) | 174M | (114M) |
| Net Change in Cash | 2.32B | (1.04B) | 5.12B | (3.13B) | 3.83B |
| Free Cash Flow | 3.3B | 5.26B | 7.25B | (490M) | 4.32B |
Centene Corporation
NYSE:CNC
Intrinsic Alpha fair value
Locked
Current Price
$67.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.